Corbus Pharmaceuticals CRBP
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 8.14 | 148 | -17.15 | -21 | -14.80 | 168 |
| 2025Q3 | 12.65 | 92 | -22.98 | -23 | -19.90 | 110 |
| 2025Q2 | 6.90 | 111 | -14.84 | -18 | -13.33 | 125 |
| 2025Q1 | 5.31 | 127 | -12.60 | -17 | -11.48 | 140 |
| 2024Q4 | 11.80 | 142 | -6.51 | -10 | -5.96 | 156 |
| 2024Q3 | 20.63 | 150 | -9.99 | -14 | -8.72 | 164 |
| 2024Q2 | 45.25 | 126 | -8.99 | -10 | -7.20 | 152 |
| 2024Q1 | 39.24 | 97 | -7 | -8.96 | 126 | |
| 2023Q4 | 6.04 | -7 | -8 | -24.85 | 28 | |
| 2023Q3 | 6.74 | 0 | -204.50 | -10 | -25.13 | 36 |
| 2023Q2 | 7.84 | 10 | -67.62 | -9 | -18.42 | 44 |
| 2023Q1 | 7.27 | 16 | -71.77 | -18 | -30.09 | 52 |
| 2022Q4 | 3.32 | 33 | -29.04 | -11 | -15.53 | 66 |
| 2022Q3 | 4.95 | 42 | -19.21 | -9 | -11.27 | 74 |
| 2022Q2 | 7.57 | 49 | -23.95 | -13 | -14.91 | 82 |
| 2022Q1 | 15.95 | 61 | -14.49 | -9 | -9.28 | 96 |
| 2021Q4 | 18.47 | 69 | -13.99 | -10 | -9.03 | 108 |
| 2021Q3 | 30.60 | 78 | -2.82 | -2 | -1.81 | 120 |
| 2021Q2 | 54.90 | 77 | -20.34 | -17 | -13.14 | 121 |
| 2021Q1 | 59.10 | 92 | -23.49 | -16 | -13.25 | 140 |